Medicare Enrolled

Dr. Steven Assalita, M.D.

Internal Medicine · Houston, TX
Low-engagement
1504 TAUB LOOP, Houston, TX 77030
7137981750
In practice since 2013 (13 years)
NPI: 1184967937 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Assalita from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Assalita? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Assalita

Dr. Steven Assalita is an internal medicine in Houston, TX, with 13 years in practice.

Between the years covered by Open Payments, Dr. Assalita received a total of $7,381 from 28 pharmaceutical and/or device companies across 158 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Assalita is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years in practice$ $7,381 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$7,381
Total received (2018-2024)
Avg $1,230/year across 6 years
Top 12% in TX for internal medicine
28
Companies
158
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,381 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$168
2023
$179
2022
$161
2020
$657
2019
$2,331
2018
$3,886

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$4,004
Amgen Inc.
$744
BIOTRONIK INC.
$438
BOSTON SCIENTIFIC CORPORATION
$382
Novartis Pharmaceuticals Corporation
$266
iRhythm Technologies, Inc.
$171
E.R. Squibb & Sons, L.L.C.
$145
PORTOLA PHARMACEUTICALS, INC.
$139
AstraZeneca Pharmaceuticals LP
$138
Medtronic, Inc.
$138
Chiesi USA, Inc.
$106
Cardiovascular Systems Inc.
$91
Boston Scientific Corporation
$83
PFIZER INC.
$80
Arineta, Inc
$74
ABIOMED
$68
Lantheus Medical Imaging, Inc.
$46
Janssen Pharmaceuticals, Inc
$41
CVRx, Inc.
$36
Medtronic Vascular, Inc.
$34
Boehringer Ingelheim Pharmaceuticals, Inc.
$26
HeartFlow, Inc.
$25
Actelion Pharmaceuticals US, Inc.
$21
Astellas Pharma US Inc
$21
Teleflex LLC
$20
Bardy Diagnostics, Inc.
$16
Amarin Pharma Inc.
$14
Regeneron Healthcare Solutions, Inc.
$12
Top 3 companies account for 70.3% of total payments
Associated products mentioned in payments ›
Accent Pacemaker · Allure Quadra RF CRT Pacemaker · Anthem CRT Pacemaker · Assurity Pacemaker · BEVYXXA · BRILINTA · Barostim Neo System · CARDENE · CHANTIX · COREVALVE EVOLUT R · CRT-Ds · Carnation Ambulatory Monitor · Confirm Rx · Connectivity and Remote care · Corlanor · DEFINITY · Durata Defibrillation ICD Lead · ELIQUIS · ENTRESTO · Ellipse ICD · FlexAbility Ablation Catheter · Fortify Assura · General - Brady · HeartMate 3 Left Ventricular Dev · HeartWare HVAD · Impella · KENGREAL · LEXISCAN · OPSUMIT MACITENTAN · Optisure Defibrillation ICD Lead · PRADAXA · PRALUENT · Percepta · Peripheral Orbital Atherectomy System · Quadra Allure MP RF CRT Pacemkr · Quadra Assura CRT Defibrillator · RELIANCE 4 FRONT · RESONATE · Repatha · SYNERGY · SpotLight · VIGILANT · VSI · Vascepa · WATCHMAN · XARELTO · ZIO XT Patch · Zio monitor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a internal medicine in Houston?
Compare internal medicines in the Houston area by procedure volume, costs, and industry payment transparency.
Browse internal medicines nearby

Geographic Context

Internal Medicines within 10 mi
2,667
Per 100K population
56.0
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Assalita is a internal medicine, and high industry engagement (low-engagement, top 12%).

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Assalita receive payments from pharmaceutical companies?
Yes. Dr. Assalita received a total of $7,381 from 28 companies across 158 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Assalita) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →